Filing Details
- Accession Number:
- 0001964245-24-000002
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2024-02-14 17:43:17
- Reporting Period:
- 2023-12-31
- Accepted Time:
- 2024-02-14 17:43:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1096056 | Luxfer Holdings Plc | LXFR | Industrial Inorganic Chemicals (2810) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1964245 | James Mark Lawday | Luxfer Holdings Plc, Lumns Lane Manchester X0 M27 8LN | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2023-05-08 | 750 | $0.00 | 2,648 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2023-05-08 | 181 | $0.00 | 2,829 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2023-05-08 | 500 | $0.00 | 3,329 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2023-05-08 | 93 | $0.00 | 3,422 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2023-05-08 | 800 | $0.00 | 4,222 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2023-05-08 | 31 | $0.00 | 4,253 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2023-05-08 | 750 | $0.00 | 5,003 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2023-05-08 | 24 | $0.00 | 5,027 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2023-05-08 | 1,613 | $14.81 | 3,414 | No | 4 | F | Direct | |
Ordinary Shares | Disposition | 2023-08-09 | 525 | $12.24 | 2,889 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock Options (Right to Buy) | Disposition | 2023-05-08 | 750 | $0.00 | 750 | $0.00 |
Ordinary Shares | Dividend Equivalent Rights | Disposition | 2023-05-08 | 181 | $0.00 | 181 | $0.00 |
Ordinary Shares | Stock Options (Right to Buy) | Disposition | 2023-05-08 | 500 | $0.00 | 500 | $0.00 |
Ordinary Shares | Dividend Equivalent Rights | Disposition | 2023-05-08 | 93 | $0.00 | 93 | $0.00 |
Ordinary Shares | Stock Options (Right to Buy) | Disposition | 2023-05-08 | 800 | $0.00 | 800 | $0.00 |
Ordinary Shares | Dividend Equivalent Rights | Disposition | 2023-05-08 | 31 | $0.00 | 31 | $0.00 |
Ordinary Shares | Stock Options (Right to Buy) | Disposition | 2023-05-08 | 750 | $0.00 | 750 | $0.00 |
Ordinary Shares | Dividend Equivalent Rights | Disposition | 2023-05-08 | 24 | $0.00 | 24 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2025-03-14 | No | 4 | M | Direct | |
0 | 2025-03-14 | No | 4 | M | Direct | |
500 | 2025-12-13 | No | 4 | M | Direct | |
51 | 2025-12-13 | No | 4 | M | Direct | |
800 | 2027-03-15 | No | 4 | M | Direct | |
87 | 2027-03-15 | No | 4 | M | Direct | |
2,250 | 2028-03-14 | No | 4 | M | Direct | |
190 | 2028-03-14 | No | 4 | M | Direct |
Footnotes
- Represents the exercise of Stock Options and related Dividend Equivalent Rights on May 8, 2023, as detailed in Table II of this Form 5. This transaction was not previously reported on Form 4 due to an inadvertent administrative error.
- Stock Options convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.
- Dividend Equivalent Rights convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.
- Represents the payment of exercise price and tax liabilities by withholding Ordinary Shares incident to the exercise of derivative securities on May 8, 2023. This transaction was not previously reported on Form 4 due to an inadvertent administrative error.
- Represents the on-market sale of 525 Ordinary Shares on August 9, 2023. This transaction was not previously reported on Form 4 due to an inadvertent administrative error.
- The subject Stock Options fully vested and became exercisable on March 14, 2023.
- Represents Dividend Equivalent Rights accrued on Stock Options, which become exercisable proportionately with the Stock Options to which they relate. Each Dividend Equivalent Right is the economic equivalent of one Ordinary Share, subject to a nominal payment of $1.00 per Ordinary Share.
- The subject Dividend Equivalent Rights fully vested and became exercisable on March 14, 2023.
- The subject Stock Options vested and became exercisable on December 13, 2022.
- The subject Stock Options fully vested and became exercisable on December 13, 2023. As of December 31, 2023, the Stock Options have not been exercised.
- The subject Dividend Equivalent Rights vested and became exercisable on December 13, 2020, December 13, 2021, and December 13, 2022.
- The subject Dividend Equivalent Rights fully vested and became exercisable on December 13, 2023. As of December 31, 2023, the Dividend Equivalent Rights have not been exercised.
- The subject Stock Options vested and became exercisable in equal installments on March 15, 2022 and March 15, 2023. The remaining Stock Options will vest and become exercisable in two equal annual installments on March 15, 2024 and March 15, 2025.
- The subject Dividend Equivalent Rights vested and became exercisable on March 15, 2022 and March 15, 2023. The remaining Dividend Equivalent Rights will vest and become exercisable in two annual installments on March 15, 2024 and March 15, 2025.
- The subject Stock Options vested and became exercisable on March 14, 2023. The remaining Stock Options vest and become exercisable in three equal annual installments beginning on March 14, 2024.
- The subject Dividend Equivalent Rights vested and became exercisable on March 14, 2023. The remaining Dividend Equivalent Rights will vest and become exercisable in three annual installments beginning on March 14, 2024.